December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
Modulation of Adhesion Molecule Expression on Human Corneal Epithelial Cells (HCEC) by the Inflammatory Mediator, CAP37
Author Affiliations & Notes
  • H Pereira
    Dept of Pathology BMSB 434 Univ Oklahoma Health Sci Ctr Oklahoma City OK
  • X Ruan
    Pathology University of Oklahoma Health Sciences Center Oklahoma City OK
  • J Chodosh
    Ophthalmology Dean A McGee Eye Institute Oklahoma City OK
  • Footnotes
    Commercial Relationships   H. Pereira, None; X. Ruan, None; J. Chodosh, None. Grant Identification: NIH AI28018-07, OCAST
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 4201. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H Pereira, X Ruan, J Chodosh; Modulation of Adhesion Molecule Expression on Human Corneal Epithelial Cells (HCEC) by the Inflammatory Mediator, CAP37 . Invest. Ophthalmol. Vis. Sci. 2002;43(13):4201.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: CAP37 an inflammatory mediator constitutively expressed in neutrophils (PMN) is an important host defense molecule. Recently, its expression was localized to corneal epithelial cells in an in vivo model of Staphylococcus aureus keratitis. The hypothesis proposed is that CAP37, either released by PMN or induced in corneal epithelial cells at the site of infection plays a pivotal role in the inflammatory response by modulating leukocyte and corneal epithelial cell functions, thereby regulating corneal inflammation and healing. Recent in vitro data from our laboratory indicates that CAP37 promotes corneal epithelial cell proliferation and migration, two important events in corneal wound healing. In this study we wished to pursue the role of CAP37 in regulating adhesion molecule expression in corneal epithelial cells, since attachment of newly formed epithelium to the extracellular matrix is essential for completing the healing process. We measured adhesion molecules ICAM-1, PECAM-1, VCAM-1 and E-selectin and alpha- and beta-integrins that are capable of binding to fibronectin, laminin, and other extracellular matrix proteins. Methods: Immortalized HCEC were treated with an optimal dose of CAP37 for 0-72 hr. Cell adhesion molecules ICAM-1, VCAM-1 PECAM-1 and E-selectin were measured by RT-PCR. Upregulation of integrin molecules on CAP37-treated HCEC were measured using flow cytometry. Results: CAP37 upregulated ICAM-1 and PECAM-1 in a time-dependent manner, with maximum upregulation observed at 4 hr. No upregulation of VCAM-1 or E-selectin mRNA was observed in response to CAP37. Flow cytometry indicated the upregulation of alpha-3 and beta-1 integrins, with peak upregulation between 12 and 24 hr. The integrin complex alpha-3beta-1 is important in mediating adhesion of corneal epithelial cells to corneal basement membrane laminins, 5 and 10. Conclusions: These findings demonstrate that CAP37 modulates corneal epithelial cell adhesion molecules involved in leukocyte-epithelial and epithelial-extracellular matrix interactions.

Keywords: 437 inflammation • 631 wound healing • 372 cornea: epithelium 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.